LINC00176 is highly expressed in hepatocellular carcinoma while depleted expression LINC00176 can impede proliferation and induce necroptosis, highlighting that reduced expression of lncRNAs may be beneficial for cancer therapy.8 In addition, LINC00176 associates with the survival condition of patients suffering from oesophageal cancer.9 Based on the results from the LncMAP website, it was evident that LINC00176 could regulate the expression of ceruloplasmin (CP) via transcription factor B‐cell CLL/lymphoma 3 (BCL3). Here, BCL3 is linked to hepatocellular carcinoma.